EP1014977A4 - Diagnosis of migraine with aura, depression and anxiety from allelic variations in dopaminergic genes - Google Patents
Diagnosis of migraine with aura, depression and anxiety from allelic variations in dopaminergic genesInfo
- Publication number
- EP1014977A4 EP1014977A4 EP97938536A EP97938536A EP1014977A4 EP 1014977 A4 EP1014977 A4 EP 1014977A4 EP 97938536 A EP97938536 A EP 97938536A EP 97938536 A EP97938536 A EP 97938536A EP 1014977 A4 EP1014977 A4 EP 1014977A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- aura
- migraine
- anxiety
- depression
- diagnosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000019901 Anxiety disease Diseases 0.000 title 1
- 208000000060 Migraine with aura Diseases 0.000 title 1
- 230000036506 anxiety Effects 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 230000003291 dopaminomimetic effect Effects 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Pain & Pain Management (AREA)
- Microbiology (AREA)
- Psychiatry (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2439996P | 1996-08-22 | 1996-08-22 | |
| US3609197P | 1997-01-17 | 1997-01-17 | |
| US36091P | 1997-01-17 | ||
| PCT/US1997/014830 WO1998007426A1 (en) | 1996-08-22 | 1997-08-21 | Diagnosis of migraine with aura, depression and anxiety from allelic variations in dopaminergic genes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1014977A1 EP1014977A1 (en) | 2000-07-05 |
| EP1014977A4 true EP1014977A4 (en) | 2000-07-05 |
Family
ID=26698401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP97938536A Withdrawn EP1014977A4 (en) | 1996-08-22 | 1997-08-21 | Diagnosis of migraine with aura, depression and anxiety from allelic variations in dopaminergic genes |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1014977A4 (en) |
| JP (1) | JP2001527520A (en) |
| AU (1) | AU737893B2 (en) |
| CA (1) | CA2263149A1 (en) |
| WO (1) | WO1998007426A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE285728T1 (en) * | 1999-02-22 | 2005-01-15 | Univ Miami | FLAP FOR A TINY CAPSULORHEXIS |
| US20010053849A1 (en) * | 1999-06-16 | 2001-12-20 | Mary Jeanne Kreek | Plural biological sample arrays, and preparation and uses thereof |
| US7053092B2 (en) | 2001-01-29 | 2006-05-30 | Otsuka Pharmaceutical Co., Ltd. | 5-HT1a receptor subtype agonist |
| AR033485A1 (en) | 2001-09-25 | 2003-12-26 | Otsuka Pharma Co Ltd | MEDICINAL SUBSTANCE OF ARIPIPRAZOL OF LOW HYGROSCOPICITY AND PROCESS FOR THE PREPARATION OF THE SAME |
| US8703772B2 (en) | 2001-09-25 | 2014-04-22 | Otsuka Pharmaceutical Co., Ltd. | Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5550021A (en) * | 1990-02-07 | 1996-08-27 | Board Of Regents, The University Of Texas System | Allelic diagnosis of susceptibility to compulsive disorder |
-
1997
- 1997-08-21 EP EP97938536A patent/EP1014977A4/en not_active Withdrawn
- 1997-08-21 AU AU40837/97A patent/AU737893B2/en not_active Ceased
- 1997-08-21 CA CA002263149A patent/CA2263149A1/en not_active Abandoned
- 1997-08-21 WO PCT/US1997/014830 patent/WO1998007426A1/en not_active Ceased
- 1997-08-21 JP JP51101298A patent/JP2001527520A/en active Pending
Non-Patent Citations (2)
| Title |
|---|
| PEROUTKA S.J.: "Dopamine and migraine", NEUROLOGY, vol. 4, no. 3, September 1997 (1997-09-01), pages 650 - 656, XP002118937 * |
| See also references of WO9807426A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1014977A1 (en) | 2000-07-05 |
| CA2263149A1 (en) | 1998-02-26 |
| AU4083797A (en) | 1998-03-06 |
| AU737893B2 (en) | 2001-09-06 |
| WO1998007426A1 (en) | 1998-02-26 |
| JP2001527520A (en) | 2001-12-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA9711119B (en) | Compatibilized silica and polymer silica-reinforced master-batch containing same. | |
| NZ329239A (en) | Compositions comprising an organic polymer and an alkoxysilane, use in waterproofing compositions | |
| ATE224931T1 (en) | CARBON COMPOSITIONS AND IMPROVED POLYMER COMPOSITIONS | |
| IL136267A0 (en) | 1,3,4-THIADIZOLES AND 1,3,4-OXADIAZOLES AS αVβ3 ANTAGONISTS | |
| HUP0104392A3 (en) | Acquired resistance npr genes and uses thereof | |
| IL153236A0 (en) | The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders | |
| HUP0002763A3 (en) | N-triazolyl-2-indolecarboxamides and their use as cck-a agonists | |
| ZA200200294B (en) | Corticotropin releasing factor receptor 2 deficient mice and uses thereof. | |
| IL127468A0 (en) | Substituted benzylidene formamides acetamides and propionamides | |
| ZA978089B (en) | 3,4-diaryloxazolone derivatives, their methods of preparation, and their use in therapeutics. | |
| EP1014977A4 (en) | Diagnosis of migraine with aura, depression and anxiety from allelic variations in dopaminergic genes | |
| FR2754270B1 (en) | GENES CODING FOR IOTA-CARRAGHENASES AND THEIR USE FOR THE PRODUCTION OF CARRAGHENAN BIODEGRADATION ENZYMES | |
| CY2482B1 (en) | Paroxetine in treatment of depression. | |
| ZA9711456B (en) | VEGF-B/receptor complex and uses thereof. | |
| BG104914A (en) | Paroxetine maleate | |
| EP1007675A4 (en) | Porcine mhc class i genes and uses thereof | |
| IS4913A (en) | Compositions containing VX 478, Zidovudine and / or 1592489 for use in the treatment of HIV | |
| McGregor | Personal projects, meaning and well-being. | |
| Simon | Heidegger's interpretation of Plato's" Sophist", 246A-259E: The analysis of'ousia'and'to on'. | |
| Berriman | The DBS 7 | |
| Wada | Part I Discourse of Law and Hidden Power Discourse of Law and Hidden Power | |
| Lee | Properties of ORMOSIL with adding organic silane in TEOS system: I | |
| Gouthier | LCR-structures and LCR-algebras | |
| Perrotta | Some Problems in the Calculus of Variations | |
| Balhorn et al. | Determination of mass; part 1, dissemination of the unit of mass: balances, weights and test rooms |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 19990322 |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 19991102 |
|
| AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20030301 |